We build true longevity by turning proven drugs into patient-friendly, affordable prescription medicines. With our ORASMART® platform technology, we scale from an initial focus on two indications to more than 30 longevity therapies across metabolic diseases, chronic care, and beyond.
Cooperation possibilities
Pipeline development, product distribution, fund-raising.
- https://www.oractive.ch
- Send an email
- Georg Toelkhaus, CFA
Some insights
We facilitate success of longevity therapies and patient outcomes through better and more patient-friendly products. Thus contributing to a healthy and happy lifespan of people.
Together with our expert network, we focus on unlocking longevity potential in underutilized, approved molecules. We overcome known limitations and systematically turn old drugs into new longevity therapies. We continuously seek input on longevity targets that can be expanded through our platform.
We marry technology and chemistry into longevity products at an affordable price that make a real difference to patients.
Maintain and gain industry visibility.
For pharma, ORACTIVE offers a unique opportunity to extend and rejuvenate portfolios by transforming proven drug substances into next-gen longevity therapies.
For investors, ORACTIVE is a platform-driven longevity company, designed to scale across multiple indications.
